HeartSciences (HSCS) Shares Outstanding (Diluted Average) (2021 - 2025)

HeartSciences has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $2.8 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 203.07% year-over-year to $2.8 million; the trailing twelve-month figure through Oct 2025 stood at $2.8 million (up 203.07% YoY), and the FY2025 full-year result was $938257.0, up 166.16% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $2.8 million, up from $1.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $7.4 million in Q1 2023, with the low at $79506.0 in Q2 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $2.3 million across 5 years, with a median of $1.1 million in 2025.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) sank 98.42% — and 2024, when it soared 735.25%.
• HeartSciences' Shares Outstanding (Diluted Average) stood at $3.3 million in 2021, then surged by 109.27% to $6.9 million in 2022, then slumped by 98.42% to $109841.0 in 2023, then soared by 735.25% to $917445.0 in 2024, then jumped by 203.07% to $2.8 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $2.8 million (Q4 2025), $1.3 million (Q3 2025), and $938257.0 (Q2 2025), per Business Quant data.